Supplementary Figure from A Randomized Comparison of Nivolumab versus Nivolumab + Docetaxel for Previously Treated Advanced or Recurrent ICI-Naïve Non–Small Cell Lung Cancer: TORG1630

Authors :: Hiroaki Okamoto
Masahiro Seike
Yasuhiro Goto
Akihiro Bessho
Katsuhiko Naoki
Takaaki Tokito
Yoshiro Nakahara
Ayumi Uchiyama
Satoru Miura
Hisashi Tanaka
Toshiyuki Harada
Yoshimasa Shiraishi
Naoki Furuya
Yosuke Kawashima
Yukiko Nakamura
Toshihiro Misumi
Yuichi Takiguchi
Tsuneo Shimokawa
Yuri Taniguchi
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary Figure from A Randomized Comparison of Nivolumab versus Nivolumab + Docetaxel for Previously Treated Advanced or Recurrent ICI-Naïve Non–Small Cell Lung Cancer: TORG1630

Full Text Access

Tools